Author Correction: Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling

Eitemau Tebyg

• Macrophages confer resistance to PI3K inhibitor GDC-0941 in breast cancer through the activation of NF-κB signaling
  gan: Usman, Muhammad Waqas, et al.
  Cyhoeddwyd: (2018)
• The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor
  gan: Tzeng, Huey-En, et al.
  Cyhoeddwyd: (2015)
• The PI3K inhibitor GDC-0941 displays promising in vitro and in vivo efficacy for targeted medulloblastoma therapy
  gan: Ehrhardt, Michael, et al.
  Cyhoeddwyd: (2014)
• Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941
  gan: Raynaud, Florence I., et al.
  Cyhoeddwyd: (2009)
• GDC-0941 activates integrin linked kinase (ILK) expression to cause resistance to GDC-0941 in breast cancer by the tumor necrosis factor (TNF)-α signaling pathway
  gan: Haifeng Chen, et al.
  Cyhoeddwyd: (2022-04-01)